5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
The South American Hemodynamic Monitoring Market is segmented by System (Minimally Invasive Monitoring Systems, Invasive Monitoring Systems, Non-invasive Monitoring Systems), Application, and Geography.
The South American hemodynamic monitoring market is expected to grow with a CAGR of 4.3% in the forecasted period. The key factors propelling the growth of this market are increase in the number of critically ill geriatric cases, rise in the prevalence of cardiac disorders and diabetes, increasing demand for home-based and non-invasive monitoring systems, advances in technology, due to funding by private players and government bodies, and increase in the number of people suffering from hypertension.
According to the World Population Ageing 2019 report, in Brazil, the population aged 65 years or over in 2019 was 19.526 million (9.3%), and this number is projected to reach to 30.413 million (13.6%) in 2030. As the number of elderly is expected to grow in the coming years, and the elderly population is more prone to chronic disorders, such as cardiovascular diseases, obesity and diabetes, the market is expected to experience growth in the future.
Thus, owing to above factors the market is expected to show significant growth over the forecast period.
As per the scope of the report, critically ill patients require continuous monitoring of their vital parameters. This is done by direct pressure monitoring systems, which are also known as hemodynamic systems. The main function of these systems is to monitor cardiac activity. The hemodynamic systems give information about blood pressure, blood volume, and fluid balance. The South American Hemodynamic Monitoring Market is segmented by system, application, and geography.
|Minimally Invasive Monitoring Systems|
|Invasive Monitoring Systems|
|Non-invasive Monitoring Systems|
|Laboratory-based Monitoring Systems|
|Home-based Monitoring Systems|
|Hospital-based Monitoring Systems|
Report scope can be customized per your requirements. Click here.
The minimally invasive systems help in tracking stroke volume continuously and offer dynamic information on fluid responsiveness. Some of the systems provide the assessment of volumetric preload variables, while others highlight the continuous measurement of central venous saturation with proprietary catheters. These variables of minimally invasive systems, along with cardiac output, deliver improved hemodynamic monitoring.
According to the Global Burden of Disease (GBD)/Institute for Health Metrics and Evaluation 2017 report, estimated that in 2017, the prevalence rate of cardiovascular diseases in Argentina was 7084.9 cases (per 100,000 population). Furthermore, according to the World health organization (WHO) 2017 report, in Argentina, approximately 60,064 or 20.83% of total deaths were caused due to coronary heart disease in the year 2017. Although heart attack remains one of the top causes of death in Argentina.
Furthermore, according to the World Population Ageing 2019 report, in Argentina, the population aged 65 years or over in 2019 was 5.035 million (11.2%), and this number is projected to reach to 6.249 million (12.7%) in 2030. As the elderly population is expected to grow in the coming years, and the elderly are more prone to chronic diseases such as cardiovascular diseases, obesity and diabetes, the segment is expected to experience growth in the future.
Thus, owing to the above-mentioned factors the segment is expected to show growth in the coming years.
To understand key trends, Download Sample Report
The South American Hemodynamic Monitoring Market is highly competitive and consists of several major players. In terms of market share, few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new devices with fewer prices. Companies, like Getinge Group, Koninklijke Philips NV, Edwards Life Sciences Corporation, and GE Healthcare, hold substantial shares in the market.
1.1 Study Assumptions
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Geriatric Population and Rise in the Prevalence of Cardiac Disorders and Diabetes
4.2.2 Increasing Demand for Home-based and Non-invasive Monitoring Systems
4.2.3 Increasing Number of People Suffering from Hypertension
4.3 Market Restraints
4.3.1 Increasing Incidences of Complications Associated with Invasive Monitoring Systems
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By System
5.1.1 Minimally Invasive Monitoring Systems
5.1.2 Invasive Monitoring Systems
5.1.3 Non-invasive Monitoring Systems
5.2 By Application
5.2.1 Laboratory-based Monitoring Systems
5.2.2 Home-based Monitoring Systems
5.2.3 Hospital-based Monitoring Systems
5.3.1 South America
188.8.131.52 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Getinge Group
6.1.2 Koninklijke Philips NV
6.1.3 Edwards Lifesciences Corporation
6.1.4 GE Healthcare
6.1.5 ICU Medical Inc
6.1.6 Cheetah Medical Inc
6.1.7 LiDCO Group PLC
6.1.8 Draeger Medical
6.1.9 Schwarzer Cardiotek GmbH
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments